Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Gaussem

Showing results (61-70 of 75) with videos related to

Pageof 8
Sort By:
Journal of Thrombosis and Haemostasis : JTH|January 30, 2015
Multimodal assessment of non-specific hemostatic agents for apixaban reversalA-C Martin, I Gouin-Thibault, V Siguret, et al.
La Revue De Medecine Interne|July 15, 2010
[Thrombocytopenia associated with iron deficiency: a rare differential diagnosis of auto-immune thrombocytopenic purpura]S Chaker, S Very, D Helley, et al.
Thrombosis and Haemostasis|December 29, 2000
Elderly patients treated with tinzaparin (Innohep) administered once daily (175 anti-Xa IU/kg): anti-Xa and anti-IIa activities over 10 daysV Siguret, E Pautas, M Février, et al.
The European Respiratory Journal|April 24, 2010
Distinct patterns of circulating endothelial cells in pulmonary hypertensionD M Smadja, L Mauge, O Sanchez, et al.
Blood|January 1, 1995
Identification of 15 different candidate causal point mutations and three polymorphisms in 19 patients with protein S deficiency using a scanning method for the analysis of the protein S active geneS Gandrille, D Borgel, V Eschwege-Gufflet, et al.
Physics in Medicine and Biology|October 21, 2017
Pulsed cavitational therapy using high-frequency ultrasound for the treatment of deep vein thrombosis in an in vitro model of human blood clotG Goudot, T Mirault, B Arnal, et al.
Bone Marrow Transplantation|October 12, 2011
Angiogenic potential of BM MSCs derived from patients with critical leg ischemiaD M Smadja, C d'Audigier, C L Guerin, et al.
British Journal of Pharmacology|September 15, 2011
Antiplatelet and antithrombotic effect of F 16618, a new thrombin proteinase-activated receptor-1 (PAR1) antagonistM Dumas, F Nadal-Wollbold, P Gaussem, et al.
The Biochemical Journal|November 22, 2001
Implication of protein S thrombin-sensitive region with membrane binding via conformational changes in the gamma-carboxyglutamic acid-rich domainD Borgel, P Gaussem, C Garbay, et al.
Revue Des Maladies Respiratoires|May 17, 2017
[The role of extracorporeal removal of CO<sub>2</sub> (ECCO<sub>2</sub>R) in the management of respiratory diseases]J L Diehl, J Boisramé-Helms, A Chardon-Couteau, et al.
Pageof 8

Showing results (61-70 of 75) with videos related to

Sort By:
Pageof 8
Journal of Thrombosis and Haemostasis : JTH|January 30, 2015
Multimodal assessment of non-specific hemostatic agents for apixaban reversalA-C Martin, I Gouin-Thibault, V Siguret, et al.
La Revue De Medecine Interne|July 15, 2010
[Thrombocytopenia associated with iron deficiency: a rare differential diagnosis of auto-immune thrombocytopenic purpura]S Chaker, S Very, D Helley, et al.
Thrombosis and Haemostasis|December 29, 2000
Elderly patients treated with tinzaparin (Innohep) administered once daily (175 anti-Xa IU/kg): anti-Xa and anti-IIa activities over 10 daysV Siguret, E Pautas, M Février, et al.
The European Respiratory Journal|April 24, 2010
Distinct patterns of circulating endothelial cells in pulmonary hypertensionD M Smadja, L Mauge, O Sanchez, et al.
Blood|January 1, 1995
Identification of 15 different candidate causal point mutations and three polymorphisms in 19 patients with protein S deficiency using a scanning method for the analysis of the protein S active geneS Gandrille, D Borgel, V Eschwege-Gufflet, et al.
Physics in Medicine and Biology|October 21, 2017
Pulsed cavitational therapy using high-frequency ultrasound for the treatment of deep vein thrombosis in an in vitro model of human blood clotG Goudot, T Mirault, B Arnal, et al.
Bone Marrow Transplantation|October 12, 2011
Angiogenic potential of BM MSCs derived from patients with critical leg ischemiaD M Smadja, C d'Audigier, C L Guerin, et al.
British Journal of Pharmacology|September 15, 2011
Antiplatelet and antithrombotic effect of F 16618, a new thrombin proteinase-activated receptor-1 (PAR1) antagonistM Dumas, F Nadal-Wollbold, P Gaussem, et al.
The Biochemical Journal|November 22, 2001
Implication of protein S thrombin-sensitive region with membrane binding via conformational changes in the gamma-carboxyglutamic acid-rich domainD Borgel, P Gaussem, C Garbay, et al.
Revue Des Maladies Respiratoires|May 17, 2017
[The role of extracorporeal removal of CO<sub>2</sub> (ECCO<sub>2</sub>R) in the management of respiratory diseases]J L Diehl, J Boisramé-Helms, A Chardon-Couteau, et al.
Pageof 8